Feature Channels: Public Health

Filters close
Newswise: Once upon a BCG vaccine
Released: 13-Dec-2021 1:10 PM EST
Once upon a BCG vaccine
La Jolla Institute for Immunology

A long, long time ago, the BCG vaccine was approved for use against tuberculosis (TB), and it's still given to infants today. For generations, the vaccine has saved lives and prevented untold suffering.

13-Dec-2021 10:05 AM EST
Chicago study finds individual housing dramatically reduced coronavirus rates in at-risk people experiencing homelessness
University of Chicago Medical Center

Providing individual hotel rooms with supports to people experiencing homelessness who were at high risk of severe COVID-19 led to a 2.5-fold decrease in SARS-CoV-2 rates compared to rates seen in Chicago city shelters, as well as improvements in other health measures and housing outcomes.

Newswise: Researchers of CONTAIN study say convalescent plasma likely had benefit in early days of COVID-19; could be used early in next pandemic
13-Dec-2021 9:00 AM EST
Researchers of CONTAIN study say convalescent plasma likely had benefit in early days of COVID-19; could be used early in next pandemic
University of Texas Health Science Center at Houston

COVID-19 convalescent plasma showed a likely benefit for patients early in the pandemic before remdesivir and corticosteroids were in use, according to results of a landmark study published today in JAMA that included physician-scientists at (UTHealth Houston.

Released: 10-Dec-2021 8:00 PM EST
Dr. Ann Shippy, MD Launches Be Resilient, Be Immune Program
Ann Shippy M.D.

Are you worried about the status of your immune system? You're not alone. People all over the globe have been feeling anxious about their health and the health of their loved ones.

   
Newswise: UTEP to Work on Solutions to Reduce Drug Use-Related HIV in the El Paso-Ciudad Juárez Border
Released: 10-Dec-2021 3:00 PM EST
UTEP to Work on Solutions to Reduce Drug Use-Related HIV in the El Paso-Ciudad Juárez Border
University of Texas at El Paso

The University of Texas at El Paso will develop a sustainable public health intervention to suppress human immunodeficiency virus (HIV) in people who use drugs in the El Paso-Ciudad Juárez border region. The initiative will be funded by a $3 million grant from the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA).

Newswise: A longer-lasting COVID vaccine? UCLA study points the way
Released: 10-Dec-2021 12:10 PM EST
A longer-lasting COVID vaccine? UCLA study points the way
University of California, Los Angeles (UCLA), Health Sciences

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.

Newswise: UF Health researcher's analysis finds new pattern of mutations in omicron variant
Released: 9-Dec-2021 4:55 PM EST
UF Health researcher's analysis finds new pattern of mutations in omicron variant
University of Florida

Immunologist David A. Ostrov, Ph.D., was asked by a worldwide consortium of scientists to analyze and map the locations of omicron’s mutations. His analysis for the Global Virus Network found omicron has substantially more mutations than the delta variant at four key sites within the virus.

Released: 9-Dec-2021 3:10 PM EST
Why SARS-CoV-2 mutations come and go, and physicians’ advice remains the same: Please vaccinate
Mayo Clinic

Mayo Clinic experts say, regardless of the variant, prevention of infection works. The vaccines reduce and prevent hospitalization and death based on current knowledge. If a person can get vaccinated or is eligible for a booster, do it now. But what about these variants? Why do they show up, and how? Here is what Mayo Clinic experts are saying:

Newswise: Antibodies Discovered at Vanderbilt for Prevention of COVID-19 Granted FDA Emergency Use Authorization
Released: 9-Dec-2021 2:35 PM EST
Antibodies Discovered at Vanderbilt for Prevention of COVID-19 Granted FDA Emergency Use Authorization
Vanderbilt University Medical Center

The combination of two monoclonal antibodies, called Evusheld, was authorized as a pre-exposure prophylaxis to prevent COVID-19 in adults and children 12 years and older who have compromised immune systems or a history of severe adverse reactions to a COVID-19 vaccine.

Newswise: Andrea Villanti Joins the Rutgers Center for Tobacco Studies and Rutgers School of Public Health
Released: 9-Dec-2021 1:35 PM EST
Andrea Villanti Joins the Rutgers Center for Tobacco Studies and Rutgers School of Public Health
Rutgers School of Public Health

Andrea Villanti, PhD, MPH, will be joining the Rutgers Center for Tobacco Studies as the deputy director in January 2022. She will also join the Rutgers School of Public Health as an associate professor in the Department of Health Behavior, Society, and Policy.

   
7-Dec-2021 2:30 PM EST
Study Estimates That More Than Half of U.S. Hospitals Not in Compliance With New Pricing Disclosure Rules in First Five Months
Johns Hopkins Bloomberg School of Public Health

A study led by researchers at the Johns Hopkins Bloomberg School of Public Health that examined U.S. hospital compliance with new rules requiring hospitals to disclose prices found wide fluctuations across states, with some states achieving 75 percent or higher compliance and others coming in at 25 percent or lower.

Released: 9-Dec-2021 8:50 AM EST
Chronic Exposure to Air Pollution May Increase Risks for ICU Admission or Death Among COVID-19 Patients, Study Find
Mount Sinai Health System

New study suggests persistent exposure to air pollutants in residential communities can impact health outcomes for COVID-19 patients

Newswise:Video Embedded exercise-during-middle-age-may-prevent-age-related-chronic-diseases
VIDEO
Released: 9-Dec-2021 8:05 AM EST
Exercise during Middle Age May Prevent Age-related Chronic Diseases
American Physiological Society (APS)

Middle-aged endurance athletes have better control of blood pressure and higher arterial elasticity than sedentary adults in the same age group.

30-Nov-2021 4:20 PM EST
Tracking Inequities and Health Impacts of Flooding
Society for Risk Analysis (SRA)

Flooding is the most expensive natural disaster in the United States, according to the National Oceanic and Atmospheric Administration (NOAA), costing the country more than $1 trillion in inflation-adjusted dollars since 1980. Rising sea level and more intense storms could be devastating for the more than 40 percent of Americans who live in coastal areas.

   
Newswise: Loyola University Medical Center Discharges 2,000th COVID-19 Patient Amid Rise in COVID Cases
Released: 8-Dec-2021 5:40 PM EST
Loyola University Medical Center Discharges 2,000th COVID-19 Patient Amid Rise in COVID Cases
Loyola Medicine

This news comes at a time of increased COVID-19 hospitalizations across Loyola Medicine. During the first week of December 2021, thirty-five patients with COVID-19 were admitted to Loyola University Medical Center, an increase of 169% over the same period last month.

Released: 8-Dec-2021 8:05 AM EST
Infection plus vaccination yields better antibodies against COVID-19 variants
American Society for Microbiology (ASM)

Antibodies against the SARS-CoV-2 spike protein produced by the immune system can help identify and fend off future infections, but not all antibodies are the same.

Newswise: E-cigs with cigarette-like nicotine delivery may help cigarette smokers quit
Released: 8-Dec-2021 8:05 AM EST
E-cigs with cigarette-like nicotine delivery may help cigarette smokers quit
Penn State College of Medicine

Electronic cigarettes with cigarette-like nicotine delivery may help some people stop smoking cigarettes, according to a new study by Penn State College of Medicine and Virginia Commonwealth University researchers.



close
5.3882